Pubblicazioni per linea Easy PGX

22 07, 2021

Alessandro Pancrazzi et al., Experience of Uncommon EGFR Mutation in Lung Scheme Quality Program: Discussing Risks and Opportunities for the Improvement of Laboratory Response

adlitterio663392022-10-14T12:20:42+02:00

1 07, 2021

Cristina Morelli et al., Perfect concordance between blood-based and normal tissue-based dihydropyrimidine dehydrogenase polymorphisms suggests that pharmacogenetic screening could be contextual to tumour molecular profiling

adlitterio663392022-10-14T12:26:31+02:00

16 04, 2021

Michela Marina et al., Combination of ultrasound and molecular testing in malignancy risk estimate of Bethesda category IV thyroid nodules: results from a single-institution prospective study

adlitterio663392022-10-21T15:49:55+02:00

7 04, 2021

Lisa Elefanti et al., The Molecular Landscape of Primary Acral Melanoma: A Multicenter Study of the Italian Melanoma Intergroup (IMI).

adlitterio663392022-10-14T12:30:58+02:00

17 03, 2021

Umberto Malapelle et al., Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective.

adlitterio663392022-10-14T14:08:31+02:00

4 03, 2021

Enea Ferlizza et al., The Roadmap of Colorectal Cancer Screening

adlitterio663392023-05-08T15:54:01+02:00

17 02, 2021

Josè Nunnari et al., Rapid EGFR evaluation from used H&E, IHC and FISH diagnostic slides with the Idylla platform

adlitterio663392022-10-14T14:11:09+02:00

4 01, 2021

Caterina De Luca et. al., RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer.

Diatech Pharmacogenetics2021-11-03T17:04:38+01:00

29 12, 2020

Vincenzo Formica et. al., Clinical Utility of Plasma KRAS, NRAS and BRAF Mutational Analysis with Real Time PCR in Metastatic Colorectal Cancer Patients—The Importance of Tissue/Plasma Discordant Cases

Diatech Pharmacogenetics2021-01-05T11:30:45+01:00

1 09, 2020

Giordano Berretta et. al., Raccomandazioni 2020 sui Farmaci Agnostici (Gruppo di Lavoro AIOM – SIAPEC-IAP – SIBIOC – SIF)

Diatech Pharmacogenetics2020-11-03T12:08:48+01:00

Precedente 567 Successivo